Literature DB >> 11331591

TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation.

T Alliston1, L Choy, P Ducy, G Karsenty, R Derynck.   

Abstract

Transforming growth factor-beta (TGF-beta), a secreted factor present at high levels in bone, inhibits osteoblast differentiation in culture; yet, the mechanism of this inhibition remains unclear. We studied the effects of TGF-beta and its effectors, the Smads, on the expression and function of the osteoblast transcription factor CBFA1. TGF-beta inhibited the expression of the cbfa1 and osteocalcin genes, whose expression is controlled by CBFA1 in osteoblast-like cell lines. This inhibition was mediated by Smad3, which interacts physically with CBFA1 and represses its transcriptional activity at the CBFA1-binding OSE2 promoter sequence. The repression of CBFA1 function by Smad3 contrasts with previous observations that Smads function as transcription activators. This repression occurred in mesenchymal but not epithelial cells, and depended on the promoter sequence. Smad3-mediated repression of CBFA1 provides a central regulatory mechanism for the inhibition of osteoblast differentiation by TGF-beta, since it inhibits both cbfa1 transcription and transcriptional activation of osteoblast differentiation genes by CBFA1. Altering Smad3 signaling influenced osteoblast differentiation in the presence or absence of TGF-beta, implicating Smad3/TGF-beta-mediated repression in autocrine regulation of osteoblast differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331591      PMCID: PMC125448          DOI: 10.1093/emboj/20.9.2254

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  92 in total

Review 1.  Signaling of transforming growth factor-beta family members through Smad proteins.

Authors:  S Itoh; F Itoh; M J Goumans; P Ten Dijke
Journal:  Eur J Biochem       Date:  2000-12

2.  Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia.

Authors:  B Lee; K Thirunavukkarasu; L Zhou; L Pastore; A Baldini; J Hecht; V Geoffroy; P Ducy; G Karsenty
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

3.  Structural and functional characterization of the transforming growth factor-beta -induced Smad3/c-Jun transcriptional cooperativity.

Authors:  J Qing; Y Zhang; R Derynck
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

4.  Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia.

Authors:  S Mundlos; F Otto; C Mundlos; J B Mulliken; A S Aylsworth; S Albright; D Lindhout; W G Cole; W Henn; J H Knoll; M J Owen; R Mertelsmann; B U Zabel; B R Olsen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

5.  Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development.

Authors:  F Otto; A P Thornell; T Crompton; A Denzel; K C Gilmour; I R Rosewell; G W Stamp; R S Beddington; S Mundlos; B R Olsen; P B Selby; M J Owen
Journal:  Cell       Date:  1997-05-30       Impact factor: 41.582

6.  Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes.

Authors:  B Kern; J Shen; M Starbuck; G Karsenty
Journal:  J Biol Chem       Date:  2000-12-05       Impact factor: 5.157

7.  Tumor necrosis factor-alpha inhibits transforming growth factor-beta /Smad signaling in human dermal fibroblasts via AP-1 activation.

Authors:  F Verrecchia; M Pessah; A Atfi; A Mauviel
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

8.  Antagonistic regulation of type I collagen gene expression by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators.

Authors:  A K Ghosh; W Yuan; Y Mori; J Varga
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

9.  Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12.

Authors:  K S Lee; H J Kim; Q L Li; X Z Chi; C Ueta; T Komori; J M Wozney; E G Kim; J Y Choi; H M Ryoo; S C Bae
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

10.  Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.

Authors:  X H Feng; X Lin; R Derynck
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

View more
  171 in total

1.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3.

Authors:  D Liu; B L Black; R Derynck
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

2.  Congenic mice provide in vivo evidence for a genetic locus that modulates intrinsic transforming growth factor β1-mediated signaling and bone acquisition.

Authors:  Aditi Mukherjee; Emily A Larson; Amy S Carlos; John K Belknap; Peter Rotwein; Robert F Klein
Journal:  J Bone Miner Res       Date:  2012-06       Impact factor: 6.741

3.  Integration of Runx and Smad regulatory signals at transcriptionally active subnuclear sites.

Authors:  Sayyed K Zaidi; Andrew J Sullivan; Andre J van Wijnen; Janet L Stein; Gary S Stein; Jane B Lian
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

4.  Endogenous TGF-beta signaling suppresses maturation of osteoblastic mesenchymal cells.

Authors:  Shingo Maeda; Makoto Hayashi; Setsuro Komiya; Takeshi Imamura; Kohei Miyazono
Journal:  EMBO J       Date:  2004-01-29       Impact factor: 11.598

5.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.

Authors:  Toru Akune; Shinsuke Ohba; Satoru Kamekura; Masayuki Yamaguchi; Ung-Il Chung; Naoto Kubota; Yasuo Terauchi; Yoshifumi Harada; Yoshiaki Azuma; Kozo Nakamura; Takashi Kadowaki; Hiroshi Kawaguchi
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

Review 6.  Tendon development and musculoskeletal assembly: emerging roles for the extracellular matrix.

Authors:  Arul Subramanian; Thomas F Schilling
Journal:  Development       Date:  2015-12-15       Impact factor: 6.868

7.  Ligand trap of the activin receptor type IIA inhibits osteoclast stimulation of bone remodeling in diabetic mice with chronic kidney disease.

Authors:  Toshifumi Sugatani; Olga A Agapova; Yifu Fang; Alycia G Berman; Joseph M Wallace; Hartmut H Malluche; Marie-Claude Faugere; William Smith; Victoria Sung; Keith A Hruska
Journal:  Kidney Int       Date:  2016-09-22       Impact factor: 10.612

8.  Genetic Engineering of Mesenchymal Stem Cells for Differential Matrix Deposition on 3D Woven Scaffolds.

Authors:  Nguyen P T Huynh; Jonathan M Brunger; Catherine C Gloss; Franklin T Moutos; Charles A Gersbach; Farshid Guilak
Journal:  Tissue Eng Part A       Date:  2018-07-13       Impact factor: 3.845

9.  Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis.

Authors:  A Rebbapragada; H Benchabane; J L Wrana; A J Celeste; L Attisano
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

Review 10.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.